Anti-phencyclidine monoclonal antibody binding capacity is not the only determinant of effectiveness, disproving the concept that antibody capacity is easily surmounted.

MLA

Pitas, Grzegorz, et al. “Anti-Phencyclidine Monoclonal Antibody Binding Capacity Is Not the Only Determinant of Effectiveness, Disproving the Concept That Antibody Capacity Is Easily Surmounted.” Drug Metabolism and Disposition: The Biological Fate of Chemicals, vol. 34, no. 6, June 2006, pp. 906–12. EBSCOhost, https://doi.org/10.1124/dmd.105.005934.

APA

Pitas, G., Laurenzana, E. M., Williams, D. K., Owens, S. M., & Gentry, W. B. (2006). Anti-phencyclidine monoclonal antibody binding capacity is not the only determinant of effectiveness, disproving the concept that antibody capacity is easily surmounted. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 34(6), 906–912. https://doi.org/10.1124/dmd.105.005934

Chicago

Pitas, Grzegorz, Elizabeth M Laurenzana, D Keith Williams, S Michael Owens, and W Brooks Gentry. 2006. “Anti-Phencyclidine Monoclonal Antibody Binding Capacity Is Not the Only Determinant of Effectiveness, Disproving the Concept That Antibody Capacity Is Easily Surmounted.” Drug Metabolism and Disposition: The Biological Fate of Chemicals 34 (6): 906–12. doi:10.1124/dmd.105.005934.